P-values, survival analyses and phase II trials.
作者信息
Fayers P
出版信息
Br J Cancer. 1994 Jun;69(6):1182-3. doi: 10.1038/bjc.1994.232.
Abstract
摘要
相似文献
1
P-values, survival analyses and phase II trials.P值、生存分析与II期试验。
Br J Cancer. 1994 Jun;69(6):1182-3. doi: 10.1038/bjc.1994.232.
2
Combined androgen blockade for salivary gland carcinoma.联合雄激素阻断治疗涎腺癌。
Lancet Oncol. 2018 Jan;19(1):e17. doi: 10.1016/S1470-2045(17)30903-8. Epub 2017 Dec 7.
3
Single-arm phase II trial design under parametric cure models.参数治愈模型下的单臂II期试验设计
Pharm Stat. 2015 May-Jun;14(3):226-32. doi: 10.1002/pst.1678. Epub 2015 Apr 1.
4
Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck.长春瑞滨联合顺铂化疗对头颈部复发性和/或转移性唾液腺癌患者的疗效和安全性
Head Neck. 2018 Jan;40(1):55-62. doi: 10.1002/hed.24933. Epub 2017 Oct 16.
5
Phase I/II--design and analysis.I/II期——设计与分析。
Front Neurol Neurosci. 2009;25:52-54. doi: 10.1159/000209474. Epub 2009 Mar 19.
6
Association between high expression of phosphorylated Akt and mammalian target of rapamycin and improved survival in salivary gland adenoid cystic carcinoma.磷酸化Akt和雷帕霉素哺乳动物靶点的高表达与涎腺腺样囊性癌生存率提高之间的关联。
Head Neck. 2017 Jun;39(6):1145-1154. doi: 10.1002/hed.24732. Epub 2017 Feb 23.
7
Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.局部晚期大唾液腺癌术后同步放化疗的疗效
Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):687-92. doi: 10.1001/archoto.2009.70.
8
Clinician-trialist rounds: 18. Should young (and old!) clinician-trialists perform single-arm Phase II futility trials?
Clin Trials. 2013;10(6):987-9. doi: 10.1177/1740774513503523. Epub 2013 Oct 1.
9
Multistage designs for phase II clinical trials: statistical issues in cancer research.II期临床试验的多阶段设计：癌症研究中的统计学问题。
Br J Cancer. 1996 Oct;74(8):1317-20. doi: 10.1038/bjc.1996.537.
10
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.雄激素剥夺疗法对转移性/复发性雄激素受体阳性唾液腺癌患者的临床疗效
Head Neck. 2016 May;38(5):724-31. doi: 10.1002/hed.23940. Epub 2015 Jun 25.
本文引用的文献
1
A randomised phase II trial of epirubicin and 5-fluorouracil versus cisplatinum in the palliation of advanced and recurrent malignant tumour of the salivary glands.表柔比星与5-氟尿嘧啶对比顺铂用于晚期复发性涎腺恶性肿瘤姑息治疗的随机II期试验
Br J Cancer. 1993 Jan;67(1):112-4. doi: 10.1038/bjc.1993.19.
Zotero 插件